HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $721,407 | +3.1% | 18,885 | -2.6% | 0.01% | +11.1% |
| Q2 2023 | $699,433 | -12.6% | 19,391 | -7.5% | 0.01% | -25.0% |
| Q1 2023 | $800,424 | -32.6% | 20,959 | +0.4% | 0.01% | -36.8% |
| Q4 2022 | $1,187,389 | +40.7% | 20,868 | -2.3% | 0.02% | +18.8% |
| Q3 2022 | $844,000 | -9.8% | 21,352 | +0.3% | 0.02% | -15.8% |
| Q2 2022 | $936,000 | +14.0% | 21,284 | +3.4% | 0.02% | +35.7% |
| Q1 2022 | $821,000 | -1.0% | 20,593 | -0.1% | 0.01% | +7.7% |
| Q4 2021 | $829,000 | -4.1% | 20,607 | -3.0% | 0.01% | -18.8% |
| Q3 2021 | $864,000 | -11.4% | 21,239 | -1.1% | 0.02% | -11.1% |
| Q2 2021 | $975,000 | +67.2% | 21,477 | +53.7% | 0.02% | +50.0% |
| Q1 2021 | $583,000 | -19.9% | 13,975 | -18.0% | 0.01% | -25.0% |
| Q4 2020 | $728,000 | – | 17,040 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |